M

Mineralys Therapeutics

Clinical-stage biopharma targeting aldosterone synthesis

Senior Medical Science Liaison - Cardiovascular

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A Pharm.D., Ph.D., M.D., or D.O. is required; other doctoral degrees are considered.
  • Senior MSL level requires 5+ years of current MSL experience; Medical Science Liaison in Scientific/Medical Affairs at a biotech or pharmaceutical company requires 3 to 5 years of current MSL experience.
  • Five or more years focused on clinical practice, clinical research, or medical research is a plus.
  • Experience in a medically related field may include post-doctoral training, such as residencies or fellowships.
  • Experience with all phases of key opinion leader development and healthcare professional engagement, including experience with drug launches.
  • Ability to drive cross-functional collaboration, deliver high-quality scientific insights, and achieve measurable outcomes aligned with corporate goals.
  • Strong interpersonal skills, including verbal and written communication and peer-to-peer professional collaboration.
  • Must be located within driving distance of a major international airport.
  • Valid U.S. driver’s license and ability to travel without restrictions are required.

Responsibilities

  • Build and maintain relationships with key opinion leaders and healthcare professionals within the assigned region.
  • Serve as the primary point of contact for field medical and scientific inquiries.
  • Serve as a subject matter expert at medical and scientific conferences, advisory boards, roundtables, clinical investigator meetings, speaker training, and internal meetings.
  • Lead or participate in project teams that support MSL strategies and tactics as delegated by MSL leadership.
  • Identify and engage healthcare stakeholders to educate them and communicate clinical, scientific, outcomes, and economic data to providers.
  • Deliver scientific presentations and training to diverse healthcare professional audiences, summarizing and communicating complex scientific information effectively.
  • Serve as a strategic partner with internal cross-functional teams.
  • Support clinical trial site activities as needed and identify and advocate for opportunities in investigator-sponsored trial research.
  • Support continuing medical education requests and activities through the unsolicited grants process.
  • Support field medical congress activities and attend national, regional, and local meetings and medical congresses as appropriate to gather competitive intelligence, develop productive medical collaborations, and attend and report on educational sessions.
  • Gather, analyze, and communicate actionable field insights to inform company strategy, clinical challenges, and patient management trends.
  • Participate and contribute in cross-functional meetings, sharing and discussing field insights with Medical Affairs, Research and Development, Commercial, and other key internal stakeholders.
  • Adhere to policies, procedures, and guidance, and conduct company business in accordance with applicable regulations, including EEO, FDA, OSHA, PDMA, EPA, and PhRMA requirements.
  • Contribute to medical affairs metrics, qualitative and quantitative MSL reports, and standard operating procedures for the MSL function.
  • Document all field activities in accordance with company policies and regulatory requirements, ensuring compliance with industry standards.

Desired Qualifications

  • Cardiology, renal, or metabolic experience is preferred.
  • Five or more years focused on clinical practice, clinical research, or medical research is a plus.

About the Company

Mineralys Therapeutics

Clinical-stage biopharma targeting aldosterone synthesis

Mineralys Therapeutics develops targeted treatments for diseases driven by dysregulated aldosterone, aiming to control blood pressure and prevent organ damage, led by lorundrostat. Lorundrostat is an oral aldosterone synthase inhibitor that blocks the CYP11B2 enzyme to lower aldosterone production, designed to reduce blood pressure with minimal cortisol disruption due to high selectivity. Compared with older non-selective MRAs, it lowers side effects by focusing on aldosterone synthesis rather than receptor blockade. The company's goal is to advance lorundrostat through late-stage trials toward regulatory approval and commercialization, while exploring expanded uses in CKD and OSA for a potential multi-hundred-billion market.

Company size
201-500
Company stage
IPO
Headquarters
Radnor Township, Pennsylvania
Founded
2020

Recently Posted Jobs

Explore more opportunities at Mineralys Therapeutics

See more jobs